Non-surgical septal reduction therapy in hypertrophic cardiomyopathy

被引：6
|
作者：
Cooper, Robert M. [1 ]
Stables, Rodney H. [1 ]
机构：
[1] Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Liverpool L14 3PE, Merseyside, England
来源：
HEART | 2018年 / 104卷 / 01期
关键词：
LEFT-VENTRICULAR OUTFLOW; SUDDEN CARDIAC DEATH; COMPLETE HEART-BLOCK; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; MUSCULAR SUBAORTIC STENOSIS; TERM PROPRANOLOL THERAPY; HIGH-RISK PATIENTS; MONTHS FOLLOW-UP; OBSTRUCTIVE CARDIOMYOPATHY; MAGNETIC-RESONANCE;
D O I：
10.1136/heartjnl-2016-309952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：73 / U235
页数：11
相关论文
共 50 条
  • [31] Ethanol septal reduction for symptomatic hypertrophic cardiomyopathy
    Lakkis, NM
    Kleiman, NS
    Killip, DM
    Spencer, WH
    CIRCULATION, 1997, 96 (08) : 1203 - 1203
  • [32] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    Desai, Milind Y.
    Owens, Anjali
    Geske, Jeffrey B.
    Wolski, Kathy
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Cremer, Paul C.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Li, Wanying
    Sterling, Lulu
    Lampl, Kathy
    Edelberg, Jay M.
    Sehnert, Amy J.
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 95 - 108
  • [33] eComment. Septal reduction therapy for hypertrophic cardiomyopathy: the need of experienced centres
    Garcia-Villarreal, Ovidio A.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 16 (01) : 9 - 10
  • [34] Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
    Maekawa, Yuichiro
    Akita, Keitaro
    Takanashi, Shuichiro
    CIRCULATION JOURNAL, 2018, 82 (08) : 1977 - 1984
  • [35] COSTS OF SEPTAL REDUCTION THERAPY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A US CLAIMS ANALYSIS
    Butzner, M.
    Sarocco, P.
    Maron, M.
    Rowin, E.
    Teng, C. C.
    Stanek, E.
    Tan, H.
    Robertson, L.
    VALUE IN HEALTH, 2021, 24 : S73 - S73
  • [36] IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Isath, Ameesh
    Lanier, Gregg M.
    Spielvogel, David
    Malekan, Ramin
    Steinmetz, Carolyn
    Semaan, Rosa
    Fishkin, Tzvi
    Panza, Julio A.
    Naidu, Srihari S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 549 - 549
  • [37] Hypertrophic Obstructive Cardiomyopathy Surgical Myectomy and Septal Ablation
    Nishimura, Rick A.
    Seggewiss, Hubert
    Schaff, Hartzell V.
    CIRCULATION RESEARCH, 2017, 121 (07) : 771 - 783
  • [38] IMPACT OF SURGICAL SEPTAL MYECTOMY ON SYNCOPE IN HYPERTROPHIC CARDIOMYOPATHY
    Orme, Nicholas
    Sorajja, Paul
    Dearani, Joseph
    Schaff, Hartzell
    Ommen, Steve
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E272 - E272
  • [39] Non surgical septal myocardial reduction by coil embolisation for hypertrophic obstructive cardiomyopathy: one year follow-up
    Durand, E.
    Mousseaux, E.
    Coste, P.
    Piliere, R.
    Dubourg, O.
    Hagege, A.
    Desnos, M.
    Lafont, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 450 - 450
  • [40] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy
    Kuhn, HJ
    CIRCULATION, 1998, 97 (07) : 708 - 709
12345